Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stabilization of Anticoagulation by Acenocoumarol: Role of Genetic Vulnerability and Risk of Drug Interactions

NCT01492777 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01492777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01492777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stabilization of Anticoagulation by Acenocoumarol: Role of Genetic Vulnerability and Risk of Drug Interactions
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
March 31, 2012
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolic diseases